world1 outlet covering this

FDA Approves First Single-Dose Generic Treatment for Influenza

First publishedJun 17, 21:32 UTC

Last updatedJul 12, 12:32 UTC · 13m ago

↻

each logo = when that outlet publishedlast updated on Braven

Story signals

How strong is this topic?

High significance means broad impact or urgency. Source trust reflects the average authority of outlets covering the story.

Significance5.3

Weighted from impact, urgency, coverage breadth, and topic sensitivity.

Source trust10.0

Average reliability level of outlets included in this topic.

Outlets1

Independent sources contributing to this topic cluster.

More outlets usually means a more confirmed developing story.

The report

The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.

Read the full report at FDA ↗

Related in the knowledge graph

organizationDrug Administration organizationFDA Approves First Single-Dose organizationGeneric Treatment organizationInfluenza. The U.S. Food organizationXofluza

Sources (1)

Avg source rating 10.0/10

FDA10